FREDERICK, Md., Feb. 28, 2013 /PRNewswire/ -- BioElectronics
Corporation (OTC PINK: BIEL), the maker of consumer medical devices
for pain and healing, announces the initiation of a series of new
clinical trials.
Hernia Study: Dr. Frederik
Berrevoetk, Current President of the Belgian Section of
Abdominal Wall Surgery at the University Hospital Ghent,
Belgium is conducting a
postoperative recovery study on bilateral inguinal hernia
repair. Hernia repair is common procedure with a relatively
high risk of reoccurrence and chronic post-surgical pain.
BioElectronics' RecoveryRx™ Surgical Recovery Therapy, with its
known clinical effects of postoperative pain reduction, improved
tensile strength, and accelerated healing, will prove to be very
beneficial for patients undergoing this complex procedure.
Osteoarthritis Pain: This study at the University Hospital
G. Martin, in Messina, Italy and
will focus on knee pain caused by osteoarthritis.
Osteoarthritis is one of the most common musculoskeletal pain
conditions and has continued to increase in prevalence in the last
two decades. ActiPatch® therapy reduces inflammation and is ideally
suited to aid considerably in this condition.
Lower Back Pain: This study, being conducted at the
University of Dunedin, Otago,
New Zealand, will add significant
information on musculoskeletal pain conditions to our clinical
data.
"We are extremely pleased to announce these new clinical trials
since they are being conducted by leading clinical investigators in
their respective fields," commented Ian Rawe Ph.D., BioElectronics
Director of Clinical Research. "All three clinical studies are
randomized, double blind placebo controlled studies, and will be a
major addition to our portfolio of clinical research."
These new studies are in addition to our other ongoing studies
at the University of British Columbia
on healing plantar fasciitis (heel pain), osteoprogenitor cell
differentiation into bone for reconstructive surgery in
Chicago, 3rd molar
extraction dental study, now progressing with the new 3D facial
imaging technology to quantitate post-surgical edema, at
Tufts Dental School, venous stasis
ulcers in Denmark, and chronic
wound case studies in various locations.
About BioElectronics Corporation
BioElectronics Corporation is an award winning medical device
developer and manufacturer of advanced medical devices. Its
products are ActiPatch® Therapy, for over-the-counter treatment of
back pain and other musculoskeletal complaints, that provides 5x
better pain relief and is 100% safer than over-the-counter drugs,
Allay™ menstrual cycle pain therapy, and RecoveryRx™ for surgical
procedures and wound care The unique therapy delivery system, using
patented technology, provides a cost-effective in-home option to
reduce soft tissue pain and inflammation, and to accelerate
healing. For more information, please see www.bielcorp.com.
Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
SOURCE BioElectronics Corporation